eISSN: 2345-6558

Free Access


 Case Report pp. 47 - 50  
  Normal alkaline phosphatase level in a patient with primary hyperparathyroidism due to parathyroid adenoma
  Behzad Einollahi, Mehrdad Taghipour, Mohsen Motalebi, Mahdi Ramezani-Binabaj
  PDF      XML      Abstract
 Mini-Review pp. 13 - 16  
  Maxillofacial radiographic changes in renal osteodystrophy
  Atul Kaushik, Monika Kaushik
  PDF      XML      Abstract
 Mini-Review pp. 17 - 19  
  Estimation of annual per capita treatment in osteoporosis
  Saleh Khodadadi, Samaneh Khodadadi
  PDF      XML      Abstract
 Review pp. 3 - 10  
  Intraoperative parathyroid hormone monitoring in primary hyperparathyroidism; resolving controversies and debates
  Michael Samir Shawky
  PDF      XML      Abstract
 Mini-Review pp. 31 - 33  
  Pulmonary hypertension and deficiency of vitamin D
  Sara Beigrezaei, Hamid Nasri
  PDF      XML      Abstract
 Original pp. 43 - 47  
  Secondary hyperparathyroidism in chronic hemodialysis patients in Khuzestan province, Iran
  Fatemeh Hayati, Seyed Seifollah Beladi Mousavi, Mohammad Faramarzi
  PDF      XML      Abstract
 Mini-Review pp. 57 - 59  
  Parathyroid carcinoma; an updated mini-review on current trends
  Mohammadreza Ardalan
  PDF      XML      Abstract
 Mini-Review pp. 66 - 68  
  Hypercalcemia and hyperparathyroidism in long-term lithium administration
  Mahrang Hedaiaty, Mahsa Hedaiaty
  PDF      XML      Abstract
 Original pp. 32 - 37  
  Relationship of circulating levels of 25(OH) vitamin D with parathyroid hormone in Iranian patients with chronic kidney disease not yet on dialysis; what is the best threshold for 25(OH) vitamin D
  Farrokhlaga Ahmadi, Zahra Mohebbi, Mitra Mahdavi-Mazdeh, Mahboob Lessan-Pezeshki
  PDF      XML      Abstract      DOI
 Hypothesis pp. 3 - 4  
  Excessive production of parathyroid hormone in association with left ventricular dysfunction in regular hemodialysis patients
  Hamid Nasri
  PDF      XML      Abstract      DOI
 Original pp. 23 - 25  
  Parathyroidectomy for children with chronic renal failure and secondary hyperparathyroidism; what is the best technique?
  Mohammed Elsherbeny, Ahmed Arafa, Mohammed Abdelsattar, Osama Elnaggar, Mosad Elbehery, Hatem Saafan, Mohammed Abdelmonaem
  PDF      XML      Abstract      DOI
 Review pp. 36 - 38  
  The need for a reliable bone biomarker to better assess chronic kidney disease mineral and bone disorder
  Ramin Tolouian, Ajay Gupta
  PDF      XML      Abstract      DOI
 Original pp. 50 - 56  
  Bone mineral density and bone metabolism biochemical markers in patients with chronic kidney disease at the hemodialysis treatment
  Mohammad Reza Tamadon, Jamileh Moghimi, Vahid Semnani
  PDF      XML      Abstract      DOI
 Commentary pp. 72 - 73  
  Magnesium and parathyroid hormone among end-stage renal disease patients
  Seyed Seifollah Beladi Mousavi, Fatemeh Hayati, Shokouh Shayanpour, Shahla Ahmadi Halili
  PDF      XML      Abstract      DOI
 Original pp. 80 - 86  
  Cinacalcet therapy for achievement of the NKF/K-DOQITM clinical practice guidelines for bone and mineral metabolism in individuals under regular hemodialysis
  Taoufiq Aatif, Najet El Esper, Philippe Moriniere, Gabriel Choukroun, Albert Fournier
  PDF      XML      Abstract      DOI
 Brief Communication pp. 64 - 67  
  Secondary hyperparathyroidism among end-stage renal disease patients in Beharlou hospital, Tehran province, Iran
  Seyed Majid Mousavi Movahed, Seyed Seifollah Beladi Mousavi, Mohammad Faramarzi
  PDF      XML      Abstract      DOI

Creative Commons Attribution 4.0 License This work is licensed under a Creative Commons Attribution 4.0 License.
Copyright © 2016 The Author(s)
Published by Nickan Research Institute